BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 31933156)

  • 1. Assessment of cardiac tumors by
    Meng J; Zhao H; Liu Y; Chen D; Hacker M; Wei Y; Li X; Zhang X; Kreissl MC
    J Nucl Cardiol; 2021 Oct; 28(5):2233-2243. PubMed ID: 31933156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of
    Zhang Y; Han J; Li J; Cao J; Zhou Y; Deng S; Zhang B; Yang Y
    J Cancer Res Clin Oncol; 2024 May; 150(5):265. PubMed ID: 38769201
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Qin C; Shao F; Hu F; Song W; Song Y; Guo J; Lan X
    Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1083-1093. PubMed ID: 31807883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accuracy of F-18 FDG PET/CT with optimal cut-offs of maximum standardized uptake value according to size for diagnosis of regional lymph node metastasis in patients with rectal cancer.
    Bae SU; Won KS; Song BI; Jeong WK; Baek SK; Kim HW
    Cancer Imaging; 2018 Sep; 18(1):32. PubMed ID: 30217167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The maximum standardized uptake value of metastatic site in 18 F-FDG PET/CT predicts molecular subtypes and survival in metastatic breast cancer: An Izmir Oncology Group study.
    Cokmert S; Tanriverdi O; Karapolat I; Demir L; Bayoglu V; Can A; Akyol M; Yilmaz Y; Oktay Tarhan M
    J BUON; 2016; 21(6):1410-1418. PubMed ID: 28039701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of dual time point PET/CT for distinguishing malignant from benign focal 18F-FDG uptake duodenal lesions.
    Sa R; Zhao HG; Dai YY; Guan F
    Medicine (Baltimore); 2018 Sep; 97(38):e12521. PubMed ID: 30235771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical value of texture analysis of dual-time-point
    Nakajo M; Jinguji M; Aoki M; Tani A; Sato M; Yoshiura T
    Eur Radiol; 2020 Mar; 30(3):1759-1769. PubMed ID: 31728684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of positron emission tomography/computed tomography and chest thin-layer high-resolution computed tomography for evaluation of pulmonary nodules: Correlation with imaging features, maximum standardized uptake value, and pathology.
    Hou S; Lin X; Wang S; Shen Y; Meng Z; Jia Q; Tan J
    Medicine (Baltimore); 2018 Aug; 97(31):e11640. PubMed ID: 30075545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting malignancy in patients with adrenal tumors using
    Vos EL; Grewal RK; Russo AE; Reidy-Lagunes D; Untch BR; Gavane SC; Boucai L; Geer E; Gopalan A; Chou JF; Capanu M; Strong VE
    J Surg Oncol; 2020 Dec; 122(8):1821-1826. PubMed ID: 32914407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiation of soft tissue and bone sarcomas from benign lesions utilizing
    Chen B; Feng H; Xie J; Li C; Zhang Y; Wang S
    BMC Med Imaging; 2020 Jul; 20(1):85. PubMed ID: 32711449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What parameters from 18F-FDG PET/CT are useful in evaluation of adrenal lesions?
    Kunikowska J; Matyskiel R; Toutounchi S; Grabowska-Derlatka L; Koperski L; Królicki L
    Eur J Nucl Med Mol Imaging; 2014 Dec; 41(12):2273-80. PubMed ID: 25027709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiation and diagnosis of benign and malignant testicular lesions using 18F-FDG PET/CT.
    Shao D; Gao Q; Tian XW; Wang SY; Liang CH; Wang SX
    Eur J Radiol; 2017 Aug; 93():114-120. PubMed ID: 28668404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of
    Xi XY; Gao W; Gong JN; Guo XJ; Wu JY; Yang YH; Yang MF
    Int J Cardiovasc Imaging; 2019 Jul; 35(7):1395-1403. PubMed ID: 30747369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The incidence of thyroid cancer in focal hypermetabolic thyroid lesions: an 18F-FDG PET/CT study in more than 6000 patients.
    Barrio M; Czernin J; Yeh MW; Palma Diaz MF; Gupta P; Allen-Auerbach M; Schiepers C; Herrmann K
    Nucl Med Commun; 2016 Dec; 37(12):1290-1296. PubMed ID: 27612034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of metabolic response with
    Segreto S; Fonti R; Ottaviano M; Pellegrino S; Pace L; Damiano V; Palmieri G; Del Vecchio S
    Cancer Imaging; 2017 Mar; 17(1):10. PubMed ID: 28264726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation Between
    Yu P; Lei J; Xu B; Wang R; Shen Z; Tian J
    Acad Radiol; 2020 May; 27(5):682-688. PubMed ID: 31311773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical features and
    Chen D; Zhu Y; Chen Y; Zhu D; Liu Z; Li T; Liu Y; Zhao K; Su X; Li L
    BMC Infect Dis; 2022 Jul; 22(1):646. PubMed ID: 35896979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple metabolic parameters and visual assessment of
    Ren Y; Liu J; Wang L; Luo Y; Ding X; Shi A; Liu J
    Abdom Radiol (NY); 2020 Nov; 45(11):3569-3580. PubMed ID: 32274551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative assessment of atherosclerotic plaques on (18)F-FDG PET/MRI: comparison with a PET/CT hybrid system.
    Li X; Heber D; Rausch I; Beitzke D; Mayerhoefer ME; Rasul S; Kreissl M; Mitthauser M; Wadsak W; Hartenbach M; Haug A; Zhang X; Loewe C; Beyer T; Hacker M
    Eur J Nucl Med Mol Imaging; 2016 Jul; 43(8):1503-12. PubMed ID: 26816195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.